LCTX · Insider Trading
Lineage Cell Therapeutics, Inc.
Every open-market purchase and sale reported by LCTX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Deborah J Andrews | Director | A | +125,000 deriv. | — |
| 2026-07-02 | Angus C. Russell | Director | A | +125,000 deriv. | — |
| 2026-07-02 | Neal C Bradsher | Director | A | +125,000 deriv. | — |
| 2026-07-02 | Anula Jayasuriya | Director | A | +125,000 deriv. | — |
| 2026-07-02 | Michael H. Mulroy | Director | A | +125,000 deriv. | — |
| 2026-07-02 | Dipti Amin | Director | A | +125,000 deriv. | — |
| 2026-03-12 | Brian M Culley | President and CEO | Buy | +15,000 | +$24.38K |
| 2026-03-06 | Jill Ann Howe | Chief Financial Officer | A | +1,050,000 deriv. | — |
| 2026-03-06 | Brian M Culley | President and CEO | A | +3,250,000 deriv. | — |
| 2026-03-06 | George A. Samuel III | General Counsel and Secretary | A | +900,000 deriv. | — |
| 2026-02-13 | Brian M Culley | President and CEO | MIXED | +18,381 | −$23.16K |
| 2026-02-13 | George A. Samuel III | General Counsel and Secretary | MIXED | +3,573 | −$4.50K |
| 2025-12-19 | Brian M Culley | President and CEO | MIXED | +8,591 | −$561 |
| 2025-12-19 | George A. Samuel III | General Counsel and Secretary | MIXED | +1,670 | −$109 |
| 2025-07-03 | Neal C Bradsher | Director | A | +75,000 deriv. | — |
| 2025-07-02 | Dipti Amin | Director | A | +75,000 deriv. | — |
| 2025-07-02 | Angus C. Russell | Director | A | +75,000 deriv. | — |
| 2025-07-02 | Deborah J Andrews | Director | A | +75,000 deriv. | — |
| 2025-07-02 | Michael H. Mulroy | Director | A | +75,000 deriv. | — |
| 2025-07-02 | Anula Jayasuriya | Director | A | +75,000 deriv. | — |
| 2025-03-12 | George A. Samuel III | General Counsel and Secretary | A | +750,000 deriv. | — |
| 2025-03-12 | Brian M Culley | President and CEO | A | +2,300,000 deriv. | — |
| 2025-03-12 | Jill Ann Howe | Chief Financial Officer | A | +750,000 deriv. | — |
| 2025-02-12 | George A. Samuel III | General Counsel | MIXED | +3,636 | −$1.59K |
| 2025-02-12 | Brian M Culley | President and CEO | MIXED | +18,702 | −$8.16K |
| 2025-01-28 | Neal C Bradsher | Director | Buy | +23,684,211 | +$18.00M |
| 2024-11-26 | George A. Samuel III | General Counsel | Buy | +15,000 | +$9.00K |
| 2024-11-26 | Jill Ann Howe | Chief Financial Officer | Buy | +15,000 | +$8.85K |
| 2024-11-25 | Michael H. Mulroy | Director | Buy | +40,000 | +$22.64K |
| 2024-11-22 | Brian M Culley | President and CEO | Buy | +40,000 | +$24.00K |
| 2024-08-19 | Jill Ann Howe | Chief Financial Officer | Buy | +10,500 | +$9.35K |
| 2024-07-03 | Michael H. Mulroy | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Dipti Amin | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Don M Bailey | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Deborah J Andrews | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Anula Jayasuriya | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Neal C Bradsher | Director | A | +75,000 deriv. | — |
| 2024-07-03 | Angus C. Russell | Director | A | +75,000 deriv. | — |
| 2024-05-28 | Brian M Culley | President and CEO | Buy | +10,000 | +$10.50K |
| 2024-03-08 | Brian M Culley | President and CEO | A | +1,900,000 deriv. | — |
| 2024-03-08 | Jill Ann Howe | Chief Financial Officer | A | +650,000 deriv. | — |
| 2024-03-08 | George A. Samuel III | General Counsel/Secretary | A | +650,000 deriv. | — |
| 2024-02-12 | George A. Samuel III | General Counsel/Secretary | MIXED | +3,586 | −$2.69K |
| 2024-02-12 | Brian M Culley | President and CEO | MIXED | +18,443 | −$13.83K |
| 2024-02-08 | Don M Bailey | Director | Buy | +96,155 | +$100.00K |
| 2024-02-08 | BROADWOOD PARTNERS, L.P. | Director | Buy | +20,192,310 | +$21.00M |
| 2024-01-02 | Anula Jayasuriya | Director | Buy | +10,000 | +$10.90K |
| 2023-07-03 | Don M Bailey | Director | A | +50,000 deriv. | — |
| 2023-07-03 | Angus C. Russell | Director | A | +50,000 deriv. | — |
| 2023-07-03 | Anula Jayasuriya | Director | A | +50,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Neal C Bradsher | Director | 99,121,984 | $99.11M |
| Michael H. Mulroy | Director | 298,555 | $298.53K |
| Brian M Culley | President and CEO | 255,516 | $255.49K |
| Angus C. Russell | Director | 87,500 | $87.49K |
| Dipti Amin | Director | 35,000 | $35.00K |
| Deborah J Andrews | Director | 34,720 | $34.72K |
| George A. Samuel III | General Counsel and Secretary | 33,565 | $33.56K |
| Jill Ann Howe | Chief Financial Officer | 25,500 | $25.50K |
| Anula Jayasuriya | Director | 10,000 | $10.00K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the LCTX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.